Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis
暂无分享,去创建一个
M. Rieder | D. Nickerson | J. Emerson | R. Gibson | F. Wright | M. Bamshad | M. Emond | K. Barnes | T. Louie | H. Tabor | R. Mathias | M. Knowles | Wei Zhao | Lung Go
[1] Binjie Zhang,et al. Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages , 2012, Journal of Cell Science.
[2] A. Choi,et al. Autophagy: a core cellular process with emerging links to pulmonary disease. , 2011, American journal of respiratory and critical care medicine.
[3] J. Shendure,et al. Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.
[4] Adam Kiezun,et al. Computational and statistical approaches to analyzing variants identified by exome sequencing , 2011, Genome Biology.
[5] Fred A. Wright,et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 , 2011, Nature Genetics.
[6] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[7] G. Cutting,et al. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients , 2010, Respiratory research.
[8] N. Schork,et al. Extremes of Unexplained Variation as a Phenotype: An Efficient Approach for Genome-Wide Association Studies of Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.
[9] E. Zeggini,et al. An Evaluation of Statistical Approaches to Rare Variant Analysis in Genetic Association Studies , 2009, Genetic epidemiology.
[10] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[11] Margaret Rosenfeld,et al. Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. , 2009, Contemporary clinical trials.
[12] T. Noda,et al. Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. , 2008, Cell structure and function.
[13] L. Dupont,et al. Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre , 2006, European Respiratory Journal.
[14] M. Kosorok,et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. , 2005, JAMA.
[15] F. Martinez,et al. Automated high-throughput sex-typing assay. , 2004, BioTechniques.
[16] P. Gøtzsche,et al. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: A marker of therapeutic success?—A 30‐year Cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection , 2004, Pediatric pulmonology.
[17] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[18] M. Denton,et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[19] J. Emerson,et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.